Working at Amsterdam UMC

PhD evaluating benefit of hyperthermia, chemotherapy and immunotherapy treatment

Do you want to investigate better treatments for metastasized ovarian cancer? Are you curious about the effectiveness of novel combined immunotherapy and Hyperthermic Intraperitoneal Chemotherapy cancer therapy? Apply now!
PhD evaluating benefit of hyperthermia, chemotherapy and immunotherapy treatment
Questions?
Apply now
36 hours per week
Beide locaties Amsterdam UMC
project
€ 3.017 - € 3.824
React until: 15 December 2024
The project

Effective treatment of tumors metastasizing to the peritoneal cavity is a major challenge. Surgery is applied to remove macroscopic lesions, this is followed by Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to remove remaining microscopic cancer. During HIPEC a chemotherapy solution heated to 40-43°C is circulated through the peritoneum for 30 to 90 minutes. The elevated temperatures during HIPEC sensitize chemotherapy and thus improve the likelihood of tumour control.

The four year multidisciplinary research project “Hyperthermia transfers immunologically cold into hot tumors: Exploring potential benefit of adding immunotherapy to HIPEC treatment of metastasized ovarian cancer” is supported by a grant of the Dutch Cancer Society KWF and aims to optimize the clinical effectiveness of the HIPEC procedure by evaluating the benefit of combining HIPEC protocols with immunotherapy. In the project immune markers are monitored in in vitro and in vivo ovarian cancer tumor models at various HIPEC temperatures, and combined with immunotherapy. Goal is to establish an optimal combined HIPEC + immunotherapy protocol resulting in more effective tumor eradication. We are looking for a PhD student with a relevant clinical, biological or veterinary medicine background. A team of biologists, physicists and clinicians of Amsterdam UMC, NKI-AVL and Cleveland Clinic will advise on the work performed by the PhD student.

This project is part of a larger research line involving the application and evaluation of the benefit of hyperthermia and HIPEC for different tumor sites, including peritoneal metastases of colorectal origin. We previously developed a dedicated small animal setup for evaluating HIPEC protocols. Examples of papers of our research line can be found in dois: 10.3390/cancers12123516, 10.3390/cells9081775, and 10.3389/fonc.2023.1122755.

Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page.

About your role
  • You will analyze cancer cell survival and cytokine expression after mimicking HIPEC treatment with and without immunotherapy in vitro on co-culture cell lines (tumor cells and T lymphocytes), on patient derived organoid structures and in an ovarian cancer mouse model treated with a dedicated well-controlled rodent HIPEC set up.
  • In parallel patient samples (tumor material and blood samples) will be collected pre- and post-HIPEC treatment to determine (intra) tumor immune responses to HIPEC and validate the clinical translation of the preclinical results.
  • Work will involve analysis, evaluation and application of immunotherapy combined with the HIPEC procedure in different tumor models, which is novel in the field of HIPEC.
  • The research project should result in a PhD thesis.
About you
  • You have a MSc degree in clinical, biological or veterinary medicine, or a related background.
  • You preferably have practical experience with animal research (Netherlands: artikel 9).
  • You have excellent analytical and communicative skills and the ability to work within a multidisciplinary research group are essential.
  • You have good command of English.
Rhiannon Sandfort
Question about this vacancy? Rhiannon Sandfort Recruitment Adviseur
If you would like more information about the application process, please contact me.
Our offer
  • A flying start to your career in scientific research.
  • Plenty of room for your drive to shape tomorrow's healthcare.
  • Working on large-scale and in-house research, with motivated colleagues from all over the world.
  • You will be employed by Amsterdam UMC Research BV.
  • We offer a contract for 4 years (48 months) with a trial period of 1 year.
  • Salary scale OIO: € 3.017 to € 3.824 gross per month based on full-time employment (depending on education and experience) and a year-end bonus of 8.3%. Doctors are placed in salary scale 10: € 3.824 tot € 5.504 gross per month based on full-time employment (depending on education and experience). Calculate your net salary here.
  • Holiday hours: 186,4 per year for fulltime and a possibility to save additional hours.
  • Pension accrual with BeFrank, a modern, comprehensible and fairly priced pension.
  • For >7 km each way, 100% reimbursement for public transport travel costs and, for private transport, €0.18 per km up to a maximum of 40 km each way.
  • Do you prefer walking or cycling? Take advantage of our good bike scheme. Moreover, you will receive a reimbursement of €0.18 per km.

Watch this video with more information about joining Amsterdam UMC Research BV.

About your workplace

Amsterdam UMC Research BV supports non-profit scientific research. In doing so, we provide researchers with everything they need to excel. Our principal investigators (PIs) and project leaders offer support in the field of project management, finance and human resources. In medical scientific research projects, legal support is also provided.

Watch the video to find out more.

The candidate will work at the Department of Radiation Oncology and the Laboratory of Experimental Radiobiology of the Amsterdam University Medical centers. The candidate will collaborate with biologists, physicists and clinicians working on HIPEC research at both locations of Amsterdam UMC.

The Amsterdam UMC and the PI’s for this project are widely acknowledged as leading experts in the field of clinical, pre-clinical and technical research on hyperthermia combined with radiotherapy or chemotherapy, as well as in the field of HIPEC. Cancer research is thriving at Amsterdam UMC and preclinical research results are readily translated into clinical practice.

Amsterdam UMC has an open culture. This means that we hope that everyone feels welcome in our organization and that we strive to offer equal opportunities to everyone. We therefore cordially invite all interested parties to respond to this vacancy. Check out our approach to diversity and inclusion.
Let’s meet!

During the publication period, applications will be handled continuously. If the vacancy is filled, it will be closed prematurely. Your CV and motivation letter will be shared with the selection committee, composed of a team from Amsterdam UMC and Antoni van Leeuwenhoek ziekenhuis.

If you have any questions about this position, please feel free to contact Hans Crezee via 020-5667963.

For more information about the application procedure, please contact Rhiannon Sandfort, Recruitment advisor, via r.e.sandfort@amsterdamumc.nl.

Please note: For this vacancy, in addition to employees of Amsterdam UMC, employees of external organizations will also take part in the selection committee. By sending your application, you agree that your cv and motivation letter will also be shared by Amsterdam UMC with (the employees involved in processing this vacancy of) the Antoni van Leeuwenhoek hospital and that they will therefore have access to the personal data you have submitted.

A reference check, screening and hiring test may be part of the procedure. Read here whether that applies to you. If you join us, we ask you for a VOG (Certificate of Good Conduct).

Internal candidates will be given priority over external candidates in case of equal suitability.

Acquisition in response to this vacancy is not appreciated.